Knowledge Hub:
Drug Delivery Devices

Found: 17 Items

As Drug Delivery Evolves, So Must Patient Training

Higher-dose and larger-volume subcutaneous therapies are creating new possibilities for drug delivery, including programs exploring the transition from intravenous (IV) to subcutaneous (SC) administration. A 2024 systematic review identified 182 clinical-stage or approved large-volume SC biopharmaceuticals, defined by the authors as doses greater than 2 mL, spanning oncology and a range of chronic disease areas.

Beyond the Device: Key Takeaways from PDA PFS 2026

The 2026 PDA Universe of Pre-Filled Syringes and Injection Devices Conference brought the drug delivery community together in Palm Springs around the theme, “Where Molecules Meet Devices: Advancing Patient-Centric Solutions.” Across the program, the intersection of drug delivery, device development, combination products, technology and user experience was front and center.

Keep ahead of pharmaceutical demand

Device Differences Matter: Why Addressing Negative Transfer Is Critical to Biosimilar Success

As biosimilar and interchangeable biologic therapies continue to expand patient access to treatment, the industry has an opportunity to focus on more than affordability and availability. The patient experience must remain a priority, particularly as new delivery devices enter the market.

What an Entrepreneurial Mindset Means in Pharma and Medical Device Development

Innovation is a constant in pharma and medical device development. But what separates true industry leaders is not just innovation—it’s an entrepreneurial mindset.

Noble’s Integrated Model

Download the infographic to see how an integrated approach can simplify the patient journey and support confidence from device strategy through long-term adherence.

How Pharma Teams Should Approach Autoinjector Device Selection and Design Strategy

Learn how pharma teams should approach autoinjector device selection and autoinjector design strategy using patient-first insights, human factors, and real-world use to reduce risk and improve adherence.

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

GLP-1 therapies continue to transform the treatment landscape for obesity and type 2 diabetes. As innovation accelerates, so too does the evolution of how these therapies are delivered.

Sustainability in Drug Delivery Is a Human Factors Challenge

As sustainability goals reshape the pharmaceutical industry, much of the conversation has focused on materials, propellants, and emissions. In respiratory drug delivery, the transition to low global warming potential (low-GWP) propellants is a prime example of this shift, with the potential to significantly reduce the environmental impact of pressurized metered-dose inhalers (pMDIs).

Noble SureStartRx™ eBook

Download our Noble SureStartRx™ eBook to learn how a confidence-first onboarding approach helps patients start and stay on therapy with scalable, manufacturer-aligned support from day one.

Designing for Reality: Why Medical Device UX Must Account for Real‑World Use

Medical devices are rarely used in ideal conditions. Patients and healthcare providers interact with devices while managing stress, distractions, physical limitations, and time pressure. Yet too often, devices are designed around best case assumptions rather than real world behavior.

Navigating Human Errors in Medical Device Usage: Insights from Human Factors Research

Precision and reliability are essential in healthcare, and medical devices play a critical role in patient safety and therapeutic outcomes. Yet even the most advanced devices can fall short if they are not used as intended. Many adverse events are not the result of device malfunction, but rather use errors—situations where outcomes differ from what was intended due to how a device is designed, interpreted, or operated.

Video: Reimagining the Patient Experience

Humanizing Product Development – Incorporating HF/UX For User-Centered Solutions

In today’s rapidly evolving healthcare landscape, successful product development requires more than technical performance and regulatory compliance. Products must be designed for the people who use them—often in high stress, real world environments where clarity, confidence, and usability matter just as much as functionality.

Image of a variety of platform training devices across different therapeutic areas.

Platform vs. Custom Training Devices: Choosing the Right Approach for Your Brand

Choosing the right training device shapes the patient experience by building familiarity, confidence, and comfort with self-administration.

The Holistic Approach to Encouraging Patient Adherence in Self-Administered Therapy

in an era where patient-centered care is at the forefront of medical advancements, ensuring that patients can successfully…

patient holding training device

Autoinjectors: Innovation in Self-Administered Training Devices

The rapid pace of technological advancements has dramatically transformed the medical field. This ushers in a new era of innovative solutions that have…

Revolutionizing Healthcare: The Rise of Self-Injection Training Devices

Revolutionizing Healthcare: The Rise of Self-Injection Training Devices

Autoinjectors are a crucial mode of drug delivery, expanding access to care by allowing patients to manage their health conditions independently and…